ENVALITH
三洋化成工業株式会社 logo

SANYO CHEMICAL INDUSTRIES,LTD.

4471・Prime Market・Chemicals

Official website
三洋化成工業株式会社 logo
SANYO CHEMICAL INDUSTRIES,LTD.4471

Business

Sanyo Chemical Industries, founded in 1949, is a manufacturer specializing in performance chemicals, comprising the company itself, 17 subsidiaries, and 6 affiliated companies. Its business spans five fields: Life & Health, Petroleum & Transportation Equipment, Plastics & Fiber, Information & Electrical/Electronics, and Environment & Housing Equipment Industry, manufacturing and selling a diverse range of high-value-added products including surfactants, urethane raw materials, lubricant additives, electrolytes, and semiconductor materials. Its main customers span a wide range of industries such as automotive, petroleum, electronics, pharmaceuticals, and textiles, and it operates globally through domestic and overseas manufacturing sites (Thailand, the United States, South Korea, etc.).

Business Model

The Group adopts a build-to-forecast production system rather than a build-to-order approach, manufacturing and stocking functional chemicals at its own factories and the production sites of consolidated subsidiaries, and selling directly to various industries. Revenue is derived from the added-value margin on products, and the Group aims to improve profit margins through reducing raw material procurement costs (the Manufacturing Transformation Initiative) and shifting its portfolio toward higher value-added products. Overseas expansion through technology licensing agreements (such as with GC Polyols in Thailand) and joint ventures also serves as a source of revenue.

Company Strengths

Multiple business divisions—including Urethane Materials, Surfactants, Functional Materials, and Fine Chemicals—each pursue their own R&D, with 351 R&D personnel group-wide (approximately one-fifth of total headcount). R&D expenses for FY2026 (ending March 2026) reached ¥5,275 million (4.1% of sales), and the company continues to generate concrete results, such as obtaining regulatory approval for Silk Elastin wound-healing materials and launching sales of new highly durable electrolyte grades.

At the end of FY2026 (ending March 2026), the equity ratio stood at 81.4%, net assets at ¥162,556 million, and the current ratio at 307.1%, indicating an extremely healthy financial base. Operating cash flow was ¥20,206 million and free cash flow was ¥14,524 million, while cash and cash equivalents increased to ¥34,378 million. A nearly debt-free financial structure supports the company's flexibility in restructuring and growth investment.

During the previous medium-term management plan period, the company decisively withdrew from the superabsorbent polymer (SAP) business and from the production of materials for polymerized toner in China. In FY2026 (ending March 2026), the cost of sales ratio declined by 3.4 percentage points year on year (from 77.5% to 74.1%), and the operating margin improved from 5.9% to 7.8%. This demonstrates a proven track record of upgrading the earnings structure through the streamlining of unprofitable businesses.

ENVALITH's Perspective

Profit attributable to owners of parent for FY2026 (ending March 2026) surged to ¥15,637 million (up 276.6% year on year), but the main driver was a temporary tax effect—the additional recognition of deferred tax assets (income taxes-deferred of ¥-7,278 million) associated with the absorption-type merger with SDP Global Co., Ltd. Income before income taxes stood at only ¥10,519 million. The forecast for net income in FY2027 (ending March 2027) is ¥9,000 million (down 42.4% year on year), indicating a significant expected decline in profit. Confirming the underlying earnings level once the tax effect fades is a key point for investment judgment.

In FY2026 (ending March 2026), the Information & Electrical/Electronics segment recorded net sales of ¥22,517 million (up 7.7% year on year) and operating profit of ¥3,595 million (up 42.0% year on year), the highest growth rate among all segments. This was driven by steady conditions in the semiconductor market and the expansion of non-automotive applications for Electrolyte for Aluminum Electrolytic Capacitors. While there is a degree of dependence on external factors such as semiconductor market trends, the company's material technology capabilities are increasingly positioned to capture market growth. The company plans to continue upfront investment in growth businesses in FY2027 (ending March 2027) as well, and the timing of the resulting investment effects warrants attention.

The inflow of low-priced products into the Japanese and Asian markets, driven by weak domestic demand and oversupply in China, represents an irreversible structural change, and continues to be a headwind for urethane raw materials in the Petroleum & Transportation Equipment Industry Field and polyurethane raw materials in the Environment & Housing Equipment Industry Field. In addition, there is a risk that rising crude oil and naphtha prices due to escalating tensions in the Middle East (with concerns of an increase from the current fiscal year's naphtha price of ¥65,300/kl) will push up raw material costs. The forecast for FY2027 (ending March 2027) assumes net sales of ¥150,000 million premised on the pass-through of raw material price increases, but whether such pass-through can be realized will be a factor determining whether results come in above or below expectations.

Growth Strategy

Having completed the withdrawal from commodity products, the company is shifting its earnings structure through concentrated investment in high-value-added products, semiconductor materials, and new businesses

Completed withdrawal from the superabsorbent polymer business and the Nantong (China) production operations, achieving the streamlining of unprofitable businesses. Going forward, the company will promote a shift toward high-value-added products such as Surfactants (for Hair Care & Toiletries) and Pharmaceutical Raw Materials & Additives. In FY2026 (ending March 2026), business structure reform expenses of ¥428 million were recorded, and the withdrawal process continues to be executed.

Priority allocation of R&D and capital investment to related materials is being made to capture the steady growth of the semiconductor market. In FY2026 (ending March 2026), operating profit in this segment reached a record high of ¥3,595 million, up 42.0% year on year. In FY2027 (ending March 2026 [FY2027]), the company plans to continue upfront investment in growth businesses, anticipating increased expenses.

The company continues to promote the 'Manufacturing Grand Reform,' aimed at improving efficiency across the entire supply chain, and the 'Production Facility Reform,' which advances the consolidation and integration of production facilities. In FY2026 (ending March 2026), cost of sales was ¥94,693 million (a significant reduction from ¥110,204 million in the previous fiscal year), and the gross profit margin improved to 25.9% (from 22.5% in the previous fiscal year), with the effects becoming evident.

At the Board of Directors meeting on May 13, 2026, the shareholder return policy was revised. The company decided to shift from the previous policy of a consolidated dividend payout ratio of 30% or more to a consolidated total return ratio of 40% or more (after securing the internal reserves necessary for growth investment), and to implement progressive dividends in principle. This will apply from FY2027 (ending March 2027), with the annual dividend planned to increase to ¥175.0 (from ¥170.0 in the previous fiscal year).

Last updated: July 19, 2026